Taken together, our data (mainly based on HR-HPV infections) and those previously reported in cohorts of various countries in Africa are in agreement with the increased HPV-induced risk of cancers in patients with CD4 < 500/mm3 and with a protective effect of ART on HIV-associated malignancies in compliant women [43]. The gene discussed is CD4; the disease is cancer.